Brought to you by 
Proacta raises $35mm through Series B round
08 Feb 2007
Executive Summary
Proacta (therapeutics for solid tumors) raised $35mm in its Series B round that was led by new investor Clarus Ventures. Other new buyer Delphi Ventures joined existing backers Alta Partners, GBS Venture Partners, affiliates of the New Zealand Venture Investment Fund (No. 8 Ventures and Endeavour iCap), Genentech, and Roche. An executive from both of the new buyer groups will join Proacta's board.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Proacta raises $35mm through Series B round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice